Zoetis
Trade Zoetis 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ZTS
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments.
ZTS Key Statistics
Stock Snapshot
Zoetis(ZTS) stock is priced at $73.14, giving the company a market capitalization of 30.52B. It carries a P/E multiple of 12.77 and pays a dividend yield of 2.71%.
On 2026-08-08, Zoetis(ZTS) stock traded between a low of $72.19 and a high of $79.24. Shares are currently priced at $73.14, which is +1.3% above the low and -7.7% below the high.
The Zoetis(ZTS)'s current trading volume is 12.78M, compared to an average daily volume of 7.84M.
In the last year, Zoetis(ZTS) shares hit a 52-week high of $160.48 and a 52-week low of $71.47.
In the last year, Zoetis(ZTS) shares hit a 52-week high of $160.48 and a 52-week low of $71.47.
ZTS News
...
Morgan Stanley lowered the firm’s price target on Zoetis (ZTS) to $85 from $99 and keeps an Overweight rating on the shares. Unlock powerful investing tools wi...
Zoetis stock has had a difficult run, with the share price down about 59.1% over the past five years, yet the current valuation checks still lean toward the sha...
Analyst ratings
55%
of 20 ratingsMore ZTS News
Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...
In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Zoetis Inc (Symbol: ZTS) has taken over the #298 spot f...
William Blair downgraded Zoetis (ZTS) to Market Perform from Outperform. Published first on TheFly – the ultimate source for real-time, market-moving breaking...
As previously reported, William Blair downgraded Zoetis (ZTS) to Market Perform from Outperform after Q2 results included worse-than-expected derm declines, con...
(RTTNews) - While reporting financial results for the second quarter on Thursday, animal health company Zoetis, Inc. (ZTS) slashed its earnings, adjusted earnin...
Zoetis (ZTS) announced the appointment of James Saccaro as Executive Vice President, CFO and COO, effective August 17. In this newly created role, Mr. Saccaro w...
(RTTNews) - Zoetis Inc. (ZTS) announced a profit for second quarter of $691 million The company's earnings totaled $691 million, or $1.65 per share. This compa...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.